Celgene to buy Juno Therapeutics for $9B
Celgene Corp said on Monday it would pay about $9 billion in cash to acquire the rest of Juno Therapeutics Inc and gain access to Juno's experimental gene therapy to treat cancer.
Monday, January 22, 2018
Celgene to buy Juno Therapeutics for $9B
Celgene to buy Juno Therapeutics for $9B
Celgene Corp said on Monday it would pay about $9 billion in cash to acquire the rest of Juno Therapeutics Inc and gain access to Juno's experimental gene therapy to treat cancer.
Related Posts:
0 comments:
Post a Comment